These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation. Tanabe M, Murase N, Demetris AJ, Todo S, Starzl TE. Transplant Proc; 1994 Jun; 26(3):1510-1. PubMed ID: 8030014 [No Abstract] [Full Text] [Related]
25. Eli Lilly Prize 1992. Study on mechanisms of graft-versus-host disease following small bowel transplantation. Pirenne J. Acta Gastroenterol Belg; 1992 Jun; 55(1):17-22. PubMed ID: 1566613 [No Abstract] [Full Text] [Related]
28. The effects of antilymphocyte serum and cyclosporine on orthotopic small bowel allografts in the rat. Diflo T, Shaffer D, Maki T, Monaco AP. Transplant Proc; 1988 Feb; 20(1 Suppl 1):200-2. PubMed ID: 3258078 [No Abstract] [Full Text] [Related]
29. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat. Fändrich F, Schröder J, Jahnke T, Dresske B, Chambers WH, Zavazava N. Transplant Proc; 1996 Dec; 28(6):3267-8. PubMed ID: 8962268 [No Abstract] [Full Text] [Related]
37. Natural killer activity is down-regulated following allogeneic small bowel transplantation. Tice DG. Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554 [No Abstract] [Full Text] [Related]
38. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation. Gasser M, Timmermann W, Vowinkel T, Tykal K, Hoppe H, Otto C, Gassel AM, Meyer D, Ulrichs K, Thiede A. Transplant Proc; 1998 Sep; 30(6):2605-6. PubMed ID: 9745510 [No Abstract] [Full Text] [Related]
39. Induction of graft-versus-host disease and rejection by sensitized small bowel allografts. Langrehr JM, Hoffman RA, Banner B, Stangl MJ, Monyhan H, Lee KK, Schraut WH. Transplantation; 1991 Sep; 52(3):399-405. PubMed ID: 1897008 [Abstract] [Full Text] [Related]